These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 23970130)

  • 1. Carbamylation of serum albumin and erythropoietin resistance in end stage kidney disease.
    Kalim S; Tamez H; Wenger J; Ankers E; Trottier CA; Deferio JJ; Berg AH; Karumanchi SA; Thadhani RI
    Clin J Am Soc Nephrol; 2013 Nov; 8(11):1927-34. PubMed ID: 23970130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal Changes in Protein Carbamylation and Mortality Risk after Initiation of Hemodialysis.
    Kalim S; Trottier CA; Wenger JB; Wibecan J; Ahmed R; Ankers E; Karumanchi SA; Thadhani R; Berg AH
    Clin J Am Soc Nephrol; 2016 Oct; 11(10):1809-1816. PubMed ID: 27445162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between responsiveness to erythropoiesis-stimulating agent and long-term outcomes in chronic hemodialysis patients: a single-center cohort study.
    Ogawa T; Shimizu H; Kyono A; Sato M; Yamashita T; Otsuka K; Nitta K
    Int Urol Nephrol; 2014 Jan; 46(1):151-9. PubMed ID: 23807369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of hyporesponsiveness to erythropoietin-stimulating agents on time-dependent mortality risk among CKD stage 5D patients: a single-center cohort study.
    Ishigami J; Onishi T; Shikuma S; Akita W; Mori Y; Asai T; Kuwahara M; Sasaki S; Tsukamoto Y
    Clin Exp Nephrol; 2013 Feb; 17(1):106-14. PubMed ID: 22752396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum albumin is strongly associated with erythropoietin sensitivity in hemodialysis patients.
    Agarwal R; Davis JL; Smith L
    Clin J Am Soc Nephrol; 2008 Jan; 3(1):98-104. PubMed ID: 18045859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease.
    Ifudu O; Feldman J; Friedman EA
    N Engl J Med; 1996 Feb; 334(7):420-5. PubMed ID: 8552143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between depressive symptoms and erythropoietin resistance in stable hemodialysis patients with adequate iron stores.
    Afsar B
    Int J Artif Organs; 2013 May; 36(5):314-9. PubMed ID: 23645578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative CKD risk prediction using homocitrulline and carbamylated albumin: two circulating markers of protein carbamylation.
    Awwad A; Rhee EP; Grams M; Choles HR; Sondheimer J; He J; Chen J; Hsu CY; Vasan RS; Kimmel PL; Wulczyn K; Berg A; Lash J; Tang M; Kalim S;
    BMC Nephrol; 2024 May; 25(1):185. PubMed ID: 38816682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal Associations among Renal Urea Clearance-Corrected Normalized Protein Catabolic Rate, Serum Albumin, and Mortality in Patients on Hemodialysis.
    Eriguchi R; Obi Y; Streja E; Tortorici AR; Rhee CM; Soohoo M; Kim T; Kovesdy CP; Kalantar-Zadeh K
    Clin J Am Soc Nephrol; 2017 Jul; 12(7):1109-1117. PubMed ID: 28490436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No difference in meeting hemoglobin and albumin targets for dialyzed children with urologic disorders.
    Lestz RM; Atkinson M; Fivush B; Furth SL
    Pediatr Nephrol; 2011 Jul; 26(7):1129-36. PubMed ID: 21424524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein Carbamylation and the Risk of ESKD in Patients with CKD.
    Kalim S; Zhao S; Tang M; Rhee EP; Allegretti AS; Nigwekar S; Karumanchi SA; Lash JP; Berg AH
    J Am Soc Nephrol; 2023 May; 34(5):876-885. PubMed ID: 36757153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin therapy, hemoglobin targets, and quality of life in healthy hemodialysis patients: a randomized trial.
    Foley RN; Curtis BM; Parfrey PS
    Clin J Am Soc Nephrol; 2009 Apr; 4(4):726-33. PubMed ID: 19339412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Woman with ESRD with Increasing Need for Erythropoietin to Maintain Hemoglobin.
    Koncicki HM; Fishbane S
    Clin J Am Soc Nephrol; 2017 Jul; 12(7):1173-1175. PubMed ID: 28522653
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of the effect of pentoxifylline on erythropoietin-resistant anemia in hemodialysis patients.
    Mohammadpour AH; Nazemian F; Khaiat MH; Tafaghodi M; Salari P; Charkazi S; Naghibi M; Shamsara J
    Saudi J Kidney Dis Transpl; 2014 Jan; 25(1):73-8. PubMed ID: 24434385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effects of Parenteral Amino Acid Therapy on Protein Carbamylation in Maintenance Hemodialysis Patients.
    Kalim S; Ortiz G; Trottier CA; Deferio JJ; Karumanchi SA; Thadhani RI; Berg AH
    J Ren Nutr; 2015 Jul; 25(4):388-92. PubMed ID: 25753604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epoetin alfa resistance in hemodialysis patients with chronic kidney disease: a longitudinal study.
    Santos EJF; Hortegal EV; Serra HO; Lages JS; Salgado-Filho N; Dos Santos AM
    Braz J Med Biol Res; 2018; 51(7):e7288. PubMed ID: 29742267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of malnutrition-inflammation complex and responsiveness to erythropoiesis-stimulating agents in long-term hemodialysis patients.
    Rattanasompattikul M; Molnar MZ; Zaritsky JJ; Hatamizadeh P; Jing J; Norris KC; Kovesdy CP; Kalantar-Zadeh K
    Nephrol Dial Transplant; 2013 Jul; 28(7):1936-45. PubMed ID: 23045431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular hypertrophy in new hemodialysis patients without symptomatic cardiac disease.
    Foley RN; Curtis BM; Randell EW; Parfrey PS
    Clin J Am Soc Nephrol; 2010 May; 5(5):805-13. PubMed ID: 20378644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlates affecting survival in chronic hemodialysis patients: the combined impact of albumin and high hemoglobin levels on improving outcomes, local and national results.
    Capelli JP; Kushner H
    Hemodial Int; 2008 Oct; 12(4):450-62. PubMed ID: 19090868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between protein-energy wasting in adults with chronic hemodialysis and the response to treatment with erythropoietin.
    González-Ortiz A; Correa-Rotter R; Vázquez-Rangel A; Vega-Vega O; Espinosa-Cuevas Á
    BMC Nephrol; 2019 Aug; 20(1):316. PubMed ID: 31412807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.